

Author: Duclos P. Hofmann C-A.
Publisher: Adis International
ISSN: 0114-5916
Source: Drug Safety, Vol.24, Iss.15, 2001-01, pp. : 1105-1112
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
In 1999, the World Health Organization (WHO) Department of Vaccines and Biologicals launched the Immunisation Safety Priority Project to boost its activities in this area, with the aim of establishing a comprehensive system to ensure the safety of all immunisations given in national immunisation programmes. Countries are the primary focus of this project. The WHO has a role to play not only because of its technical and normative role but also because of its privileged relationship with country authorities and other partners, its global vision and mandate, and because it is perceived as free from conflicts of interest. There are four areas of focus in the project:
The project emphasises the importance of advocating safety and developing necessary infrastructure and human resource to properly deal with immunisation related safety issues at a national level.
Related content


Combination vaccines essential for immunisation schedules
Inpharma, Vol. 1, Iss. 1229, 2000-01 ,pp. :


Technologies to Improve Immunisation Safety
By Clements C.J. Aguado M.T. Jódar L.
Drug Safety, Vol. 24, Iss. 14, 2001-01 ,pp. :




World Health Organization Classification of Myelodysplastic Syndromes
Current Pharmaceutical Design, Vol. 18, Iss. 22, 2012-07 ,pp. :


One in four biologicals subject to safety actions postapproval
Reactions Weekly, Vol. 1, Iss. 1226, 2008-01 ,pp. :